Thirty-seven MM patients were studied, of whom 22 were at diagnosis and then all 37 at relapse before lenalidomide-dexamethasone treatment (RD)....Decreased has-miR-16 expression at diagnosis was related to better survival (p=0.16)....We observed correlations between factors of MM disease activity and hsa-miR-16 and hsa-miR-21 while in addition hsa-miR-16 expression levels predicted survival.